genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2022
AbCellera
Coronavirus
FDA Grants Lilly EUA for COVID-19 Antibody Bebtelovimab
Drug Discovery
Beyond COVID-19: AbCellera Partners with Moderna to Develop mRNA-Encoded Antibodies
Coronavirus
AbCellera, Lilly Advance Next-Generation Antibody vs. COVID-19
Drug Discovery
AbCellera’s CEO: Flattening the Curve of Technology Development
Coronavirus
To Develop Coronavirus Treatment, Lilly Taps AbCellera Antibody Platform
Drug Discovery
Novartis Creates “Inflection Point” for AbCellera with 10-Target Antibody Collaboration
Drug Discovery
Merck & Co., AbCellera Launch Antibody Collaboration
Scroll Up
Scroll Up
